This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kadokami, T. Articles by Takeshita, A. Search for Related Content PubMed PubMed Citation Articles by Kadokami, T. Articles by Takeshita, A.

(Circulation. 1996;94:190-196.)
© 1996 American Heart Association, Inc.

Articles

Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1ß In Vivo

Toshiaki Kadokami, MD; Hiroaki Shimokawa, MD; Yoshihiro Fukumoto, MD; Akira Ito, MD; Tsuneo Takayanagi, MS; Kensuke Egashira, MD; Akira Takeshita, MD

the Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University School of Medicine, Fukuoka, Japan.

Correspondence to Hiroaki Shimokawa, MD, Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-82, Japan.

Background The intracellular mechanism for coronary artery spasm is still unknown. Since the protein kinase C (PKC)–mediated pathway and Ca²⁺ release from sarcoplasmic reticulum (SR) are important intracellular mechanisms of vascular smooth muscle contraction, we examined the possible role of these two mechanisms in the pathogenesis of coronary spasm in our swine model in vivo.

Methods and Results In 25 pigs, interleukin-1ß (IL-1ß) was applied chronically to the coronary arteries from the adventitia to induce an inflammatory/proliferative lesion. Two weeks after the operation, either intracoronary serotonin or histamine repeatedly induced coronary spasm at the IL-1ß–treated site. At those spastic sites, phorbol-12,13-dibutyrate, a PKC-activating phorbol ester, also induced coronary spasm, which was blocked by pretreatment with the PKC inhibitors staurosporine and sphingosine. Serotonin- and histamine-induced coronary spasm was also significantly inhibited by pretreatment with staurosporine, sphingosine, or nifedipine (an L-type Ca²⁺ channel antagonist) but not by ryanodine (an inhibitor of Ca²⁺-induced Ca²⁺ release from SR) or thapsigargin (an inhibitor of Ca²⁺-ATPase of SR). Bay K 8644 (an L-type Ca²⁺ channel agonist) also induced coronary spasm at the IL-1ß–treated site, which was significantly inhibited by pretreatment with staurosporine, sphingosine, and nifedipine. In contrast, coronary vasoconstriction induced by prostaglandin F₂ was not affected by pretreatment with staurosporine or sphingosine but was significantly inhibited by pretreatment with ryanodine, thapsigargin, or nifedipine.

Conclusions These results suggest that (1) PKC activation largely accounts for the serotonin- and histamine-induced coronary spasm; (2) at the spastic site, the calcium influx through L-type Ca²⁺ channels may be augmented via the PKC-mediated pathway; and (3) the Ca²⁺ release from the SR into the cytosol may not play a primary role in coronary spasm.

Key Words: vasospasm • cytokines • protein kinase C • calcium channels • signal transduction

This article has been cited by other articles:

				K. Budzyn, M. Paull, P. D. Marley, and C. G. Sobey Segmental Differences in the Roles of Rho-Kinase and Protein Kinase C in Mediating Vasoconstriction J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 791 - 796. [Abstract] [Full Text] [PDF]

				Q. Liu, Z.-Q. Chen, G. C. Bobustuc, J. M. McNatt, H. Segall, S. Pan, J. T. Willerson, and P. Zoldhelyi Local Gene Transduction of Cyclooxygenase-1 Increases Blood Flow in Injured Atherosclerotic Rabbit Arteries Circulation, April 12, 2005; 111(14): 1833 - 1840. [Abstract] [Full Text] [PDF]

				T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Eto, K. Morishige, Y. Matsumoto, K. Obara, K. Nakayama, S. Takahashi, et al. Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2209 - 2214. [Abstract] [Full Text] [PDF]

				T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, K. Morikawa, M. Ito, S. Takahashi, K. Kaibuchi, and A. Takeshita Involvement of Rho-Kinase in Agonists-Induced Contractions of Arteriosclerotic Human Arteries Arterioscler. Thromb. Vasc. Biol., February 1, 2002; 22(2): 243 - 248. [Abstract] [Full Text] [PDF]

				T. P Woodsome, M. Eto, A. Everett, D. L Brautigan, and T. Kitazawa Expression of CPI-17 and myosin phosphatase correlates with Ca2+ sensitivity of protein kinase C-induced contraction in rabbit smooth muscle J. Physiol., September 1, 2001; 535(2): 553 - 564. [Abstract] [Full Text] [PDF]

				E. Sasaki, Y. Tanahashi, Y. Yamasaki, N. Oda, Y. Nozawa, H. Terakawa, K. Miyoshi, Y. Muranaka, H. Miyake, and N. Matsuura Inhibitory Effect of TAS-301, a New Synthesized Constrictive Remodeling Regulator, on Renarrowing after Balloon Overstretch Injury of Porcine Coronary Artery J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1043 - 1050. [Abstract] [Full Text]

				T. Kandabashi, H. Shimokawa, K. Miyata, I. Kunihiro, Y. Kawano, Y. Fukata, T. Higo, K. Egashira, S. Takahashi, K. Kaibuchi, et al. Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1{beta} Circulation, March 21, 2000; 101(11): 1319 - 1323. [Abstract] [Full Text] [PDF]

				A. Mazur, D. M. Roden, and M. E. Anderson Systemic Administration of Calmodulin Antagonist W-7 or Protein Kinase A Inhibitor H-8 Prevents Torsade de Pointes in Rabbits Circulation, December 14, 1999; 100(24): 2437 - 2442. [Abstract] [Full Text] [PDF]

				K. Miyata, H. Shimokawa, T. Yamawaki, I. Kunihiro, X. Zhou, T. Higo, E. Tanaka, N. Katsumata, K. Egashira, and A. Takeshita Endothelial Vasodilator Function Is Preserved at the Spastic/Inflammatory Coronary Lesions in Pigs Circulation, September 28, 1999; 100(13): 1432 - 1437. [Abstract] [Full Text] [PDF]

				H. Shimokawa, M. Seto, N. Katsumata, M. Amano, T. Kozai, T. Yamawaki, K. Kuwata, T. Kandabashi, K. Egashira, I. Ikegaki, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm Cardiovasc Res, September 1, 1999; 43(4): 1029 - 1039. [Abstract] [Full Text] [PDF]

				J. F. Beltrame, S. Sasayama, and A. Maseri Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and caucasian patients J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1442 - 1452. [Abstract] [Full Text] [PDF]

				N. Katsumata, H. Shimokawa, M. Seto, T. Kozai, T. Yamawaki, K. Kuwata, K. Egashira, I. Ikegaki, T. Asano, Y. Sasaki, et al. Enhanced Myosin Light Chain Phosphorylations as a Central Mechanism for Coronary Artery Spasm in a Swine Model With Interleukin-1ß Circulation, December 16, 1997; 96(12): 4357 - 4363. [Abstract] [Full Text]

				Y. Fukumoto, H. Shimokawa, T. Kozai, T. Kadokami, K. Kuwata, Y. Yonemitsu, T. Kuga, K. Egashira, K. Sueishi, and A. Takeshita Vasculoprotective Role of Inducible Nitric Oxide Synthase at Inflammatory Coronary Lesions Induced by Chronic Treatment With Interleukin-1ß in Pigs in Vivo Circulation, November 4, 1997; 96(9): 3104 - 3111. [Abstract] [Full Text]

				K. Nobe and R. J. Paul Distinct Pathways of Ca2+ Sensitization in Porcine Coronary Artery : Effects of Rho-Related Kinase and Protein Kinase C Inhibition on Force and Intracellular Ca2+ Circ. Res., June 22, 2001; 88(12): 1283 - 1290. [Abstract] [Full Text] [PDF]